CD41 Antibody AAGH-9 / ITGA2B Monoclonal Antibody [clone AAGH-9] (RQ5218)

CD41 Antibody AAGH-9 Staining in Human Squamous Carcinoma by IHC. Immunohistochemistry of paraffin-embedded human squamous carcinoma using CD41 Antibody (clone AAGH-9) at a 1:50 dilution shows prominent brown staining within portions of the tumor and surrounding stromal tissue. The signal is readily distinguished from the blue hematoxylin-counterstained nuclei, with heterogeneous staining intensity across the field. This tissue pattern demonstrates detection of the ITGA2B antigen using this ITGA2B Monoclonal Antibody.

CD41 Antibody AAGH-9 Staining in Human Placenta by IHC. Immunohistochemistry of paraffin-embedded human placenta using CD41 Antibody (clone AAGH-9) at a 1:50 dilution shows widespread brown staining associated with placental villous structures. Signal is visible along and within numerous villi, with blue hematoxylin-counterstained nuclei providing clear tissue contrast. The heterogeneous but extensive staining demonstrates detection of CD41/ITGA2B in human placental tissue using this ITGA2B Monoclonal Antibody.

CD41 Antibody AAGH-9 Staining in Rat Pancreas by IHC. Immunohistochemistry of paraffin-embedded rat pancreas using CD41 Antibody (clone AAGH-9) at a 1:50 dilution shows relatively light, localized brown staining within the pancreatic tissue. Signal is present along portions of the tissue architecture and in scattered cellular structures, while much of the field remains lightly stained. The observed cross-species reactivity demonstrates recognition of rat ITGA2B using this ITGA2B Monoclonal Antibody.

CD41 Antibody AAGH-9 Detection in HEL Human Erythroleukemia Cells by WB. Western blot analysis of human HEL erythroleukemia cell lysate using CD41 Antibody (clone AAGH-9) shows a strong, discrete band migrating at approximately 120-130 kDa. The observed signal is consistent with the expected migration range of the glycosylated CD41/ITGA2B protein, which has a predicted molecular weight of approximately 113 kDa before post-translational modification. Minimal additional reactivity is visible across the remainder of the lane, producing a relatively clean detection profile. This result demonstrates recognition of CD41 in HEL cells using this ITGA2B Monoclonal Antibody.